El Foro sobre Drogas de la Sociedad Civil ha publicado una encuesta para medir la accesibilidad y calidad de  iniciativas clave para la disminución de la demanda y reducción de daños. Más información, en inglés, está disponible abajo.

This survey is a part of a larger research project by the Civil Society Forum on Drugs aiming to assess the state of implementation of the EU Action Plan on Drugs 2017-2020 in the EU Member States and beyond. It is addressed to civil society organisations working in the field of drug policy.

The Civil Society Forum on Drugs (CSFD) is an expert group of the European Commission. Its members are selected by the Commission for a three-year mandate based on their competencies, knowledge, and expertise. One of its thematic working groups is concerned with the EU drug strategies and action plans.

Following the survey conducted at the beginning of the Action Plan 2017-2020 implementation (report can be accessed here), the CSFD continues the monitoring of accessibility and quality of key demand reduction and harm reduction measures. This survey aims to collect the data allowing for the evaluation of the current situation and identify the potential changes taking place during the last three years. Its results, complemented with other elements of this research project, will be published on the CSFD website.

Please, fill in the questionnaire providing answers according to your best expert knowledge. If you have any questions, please contact Iga Jeziorska, the Chair of the Working Group on the EU Action Plan, at:
Thank you for your contribution!